These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29873707)

  • 1. Spotlight on… Gabriella Campadelli-Fiume.
    Campadelli-Fiume G
    FEMS Microbiol Lett; 2018 Jun; 365(11):. PubMed ID: 29873707
    [No Abstract]   [Full Text] [Related]  

  • 2. A Strategy for Cultivation of Retargeted Oncolytic Herpes Simplex Viruses in Non-cancer Cells.
    Leoni V; Gatta V; Casiraghi C; Nicosia A; Petrovic B; Campadelli-Fiume G
    J Virol; 2017 May; 91(10):. PubMed ID: 28250120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viruses for tumor therapy.
    Bell J; McFadden G
    Cell Host Microbe; 2014 Mar; 15(3):260-5. PubMed ID: 24629333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular basis of herpesviruses as oncolytic agents.
    Menotti L; Campadelli-Fiume G; Nanni P; Lollini PL; De Giovanni C
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1795-803. PubMed ID: 21740356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advance in herpes simplex viruses for cancer therapy.
    Liu S; Dai M; You L; Zhao Y
    Sci China Life Sci; 2013 Apr; 56(4):298-305. PubMed ID: 23564184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncolytic Virotherapy by HSV.
    Watanabe D; Goshima F
    Adv Exp Med Biol; 2018; 1045():63-84. PubMed ID: 29896663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic virotherapy.
    Sze DY; Reid TR; Rose SC
    J Vasc Interv Radiol; 2013 Aug; 24(8):1115-22. PubMed ID: 23885911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Talimogene laherparepvec (Imlygic) for unresectable melanoma.
    Med Lett Drugs Ther; 2016 Jan; 58(1486):8-9. PubMed ID: 26761342
    [No Abstract]   [Full Text] [Related]  

  • 9. A pox on your tumor.
    Williams DA
    Mol Ther; 2006 Sep; 14(3):313. PubMed ID: 16844420
    [No Abstract]   [Full Text] [Related]  

  • 10. Turning killer into cure -- the story of oncolytic herpes simplex viruses.
    Zhang SX
    Discov Med; 2015 Nov; 20(111):303-9. PubMed ID: 26645902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel oncolytic viruses: riding high on the next wave?
    Stanford MM; Bell JC; Vähä-Koskela MJ
    Cytokine Growth Factor Rev; 2010; 21(2-3):177-83. PubMed ID: 20219409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic vaccinia virus: a silver bullet?
    Lusky M; Erbs P; Foloppe J; Acres RB
    Expert Rev Vaccines; 2010 Dec; 9(12):1353-6. PubMed ID: 21105770
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent advances in oncolytic adenovirus therapies for cancer.
    Rosewell Shaw A; Suzuki M
    Curr Opin Virol; 2016 Dec; 21():9-15. PubMed ID: 27379906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic virus therapy using genetically engineered herpes simplex viruses.
    Todo T
    Front Biosci; 2008 Jan; 13():2060-4. PubMed ID: 17981691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic HSV as a vector in cancer immunotherapy.
    Li H; Zhang X
    Methods Mol Biol; 2010; 651():279-90. PubMed ID: 20686972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fighting fire with fire: rewiring tumor cells for oncolytic virotherapy.
    Mahoney DJ; Stojdl DF
    Future Oncol; 2012 Mar; 8(3):219-21. PubMed ID: 22409457
    [No Abstract]   [Full Text] [Related]  

  • 17. A strategy for systemic delivery of the oncolytic herpes virus HSV1716: redirected tropism by antibody-binding sites incorporated on the virion surface as a glycoprotein D fusion protein.
    Conner J; Braidwood L; Brown SM
    Gene Ther; 2008 Dec; 15(24):1579-92. PubMed ID: 18701918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Armed interference: oncolytic viruses engineered to carry antitumor shRNAs.
    Kirn D
    Mol Ther; 2007 Feb; 15(2):227-8. PubMed ID: 17235298
    [No Abstract]   [Full Text] [Related]  

  • 19. Oncolytic viruses: immune or cytolytic therapy?
    Bell J
    Mol Ther; 2014 Jul; 22(7):1231-1232. PubMed ID: 24981435
    [No Abstract]   [Full Text] [Related]  

  • 20. Biological therapy with oncolytic herpesvirus.
    Benencia F; Coukos G
    Adv Exp Med Biol; 2008; 622():221-33. PubMed ID: 18546631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.